Pharmaceutical Mergers and Their Effect on Access and Efficiency: A Case of Emerging Markets
25 Pages Posted: 24 Apr 2016 Last revised: 26 Apr 2016
Date Written: April 20, 2016
The pharmaceutical M&As in emerging markets may jeopardies cheap access to generics. This may be a motivation for policy makers to use competition law as a tool to deter cross-border M&As. Additionally, M&As in pharmaceutical sector may also give rise to certain efficiencies. However, it is not clear as to how efficiencies will be treated in the peculiar socio-economic context of emerging markets. This paper develops a theoretical framework, which argues that the application of competition law is guided by sector-specific socio-economic realities and institutional realities of the jurisdiction. Thereafter, it employs this framework to analyze both the issues.
Keywords: pharmaceuticals, M&A, access, efficiency, competition law, emerging markets
JEL Classification: K4, K21, L40
Suggested Citation: Suggested Citation